M.D. Gregory Berk - 15 Jul 2022 Form 4 Insider Report for GT Biopharma, Inc. (GTBP)

Role
Pres. of R&D, CMO
Signature
/s/ Gregory Berk, M.D.
Issuer symbol
GTBP
Transactions as of
15 Jul 2022
Net transactions value
$0
Form type
4
Filing time
19 Jul 2022, 21:44:55 UTC
Previous filing
14 Feb 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GTBP Option to purchase Common Stock Award $0 +50,000 $0.000000 50,000 15 Jul 2022 Common Stock 50,000 $2.48 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.